Author
Listed:
- Gerd Rippin
(IQVIA)
- Héctor Sanz
(IQVIA)
- Wilhelmina E. Hoogendoorn
(IQVIA)
- Nicolás M. Ballarini
(IQVIA)
- Joan A. Largent
(IQVIA)
- Eleni Demas
(IQVIA)
- Douwe Postmus
(European Medicines Agency)
- Theodor Framke
(European Medicines Agency
Hannover Medical School)
- Lukas M. Aguirre Dávila
(Paul-Ehrlich-Institut)
- Chantal Quinten
(European Medicines Agency)
- Francesco Pignatti
(European Medicines Agency)
Abstract
Background and Objective Missing data and unmeasured confounding are key challenges for external comparator studies. This work evaluates bias and other performance characteristics depending on missingness and unmeasured confounding by means of two case studies and simulations. Methods Two case studies were constructed by taking the treatment arms from two randomised controlled trials and an external real-world data source that exhibited substantial missingness. The indications of the randomised controlled trials were multiple myeloma and metastatic hormone-sensitive prostate cancer. Overall survival was taken as the main endpoint. The effects of missing data and unmeasured confounding were assessed for the case studies by reporting estimated external comparator versus randomised controlled trial treatment effects. Based on the two case studies, simulations were performed broadening the settings by varying the underlying hazard ratio, the sample size, the sample size ratio between the experimental arm and the external comparator, the number of missing covariates and the percentage of missingness. Thereby, bias and other performance metrics could be quantified dependent on these factors. Results For the multiple myeloma external comparator study, results were in line with the randomised controlled trial, despite missingness and potential unmeasured confounding, while for the metastatic hormone-sensitive prostate cancer case study missing data led to a low sample size, leading overall to inconclusive results. Furthermore, for the metastatic hormone-sensitive prostate cancer study, missing data in important eligibility criteria led to further limitations. Simulations were successfully applied to gain a quantitative understanding of the effects of missing data and unmeasured confounding. Conclusions This exploratory study confirmed external comparator strengths and limitations by quantifying the impact of missing data and unmeasured confounding using case studies and simulations. In particular, missing data in key eligibility criteria were seen to limit the ability to derive the external comparator target analysis population accurately, while simulations demonstrated the magnitude of bias to expect for various settings.
Suggested Citation
Gerd Rippin & Héctor Sanz & Wilhelmina E. Hoogendoorn & Nicolás M. Ballarini & Joan A. Largent & Eleni Demas & Douwe Postmus & Theodor Framke & Lukas M. Aguirre Dávila & Chantal Quinten & Francesco Pi, 2024.
"Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations,"
Drug Safety, Springer, vol. 47(12), pages 1245-1263, December.
Handle:
RePEc:spr:drugsa:v:47:y:2024:i:12:d:10.1007_s40264-024-01467-9
DOI: 10.1007/s40264-024-01467-9
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:47:y:2024:i:12:d:10.1007_s40264-024-01467-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.